Gastroenterology
Hepatitis
More in Hepatitis
23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some
Dec 04, 2024
GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial
Jun 08, 2024